Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Protagen

Premium
Affymetrix last week launched its Targeted Genotyping Bovine 25K SNP Service, which includes an assay panel designed to help agricultural researchers improve the health of cattle. 
 
The SNPs included in the panel were discovered by the Bovine Genome Sequencing Project and Australia’s Commonwealth Scientific and Industrial Research Organisation. The Targeted Genotyping Bovine 25K SNP Panel is an extension of Affymetrix’ Targeted Genotyping Bovine 10K SNP product, which was introduced in June 2005, Affy said.
 
The panel is available through the Affymetrix Services Lab. The company plans to offer the Targeted Genotyping Bovine 25K SNP Service through its network of service providers once the initial launch phase is complete.
 

 
The US Food and Drug Administration has awarded protein array firm Protagen good manufacturing practice certification, the company said last week. Protagen said it will now offer protein analysis services in accordance with international quality assurance guidelines.
 

Protagen added that it has recently completed a program of work under GMP for Hamburg, Germany-based Nordmark Pharma and will now introduce its GMP services to a wider circle of pharmaceutical customers.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.